Skip to content Skip to menu Skip to footer

FinVector is a fast-growing and internationally renowned biopharmaceutical company that develops and manufactures viral-based gene therapy products. As a pioneer in its operational field, FinVector has extensive experience of nearly 30 years in cGMP manufacturing. The company’s operations are centered in Kuopio, Finland, and it employs around 330 professionals from over 30 different countries. FinVector works on cutting-edge biopharmaceuticals and has invested in building state-of-the-art development and GMP facilities for Viral Vector and Cell Therapy platforms including vaccines. FinVector is owned by Ferring Ventures, a subsidiary of Ferring Foundation B.V.

Learn more: www.finvector.com

Hot jobs

More information coming soon! Check our open positions www.finvector.com/careers

For working with us you will need to have EU work permit.

Informations sur l’organisme
Coordonnées de contact:

Instructions for using the chat room: When you want to enter the chat room, it may already be occupied by another job seeker and you will be placed in the lobby. Please wait until you are invited in. If possible prepare some questions that you want to ask and know about our company. We are available in the chat room at 10-13:30 CET except 11:00-11:30 CET we are unavailable.

Visit our website:

https://www.finvector.com/

info@finvector.com

Event participation(s)

à passé
05 octobre 2022
Participation: En ligne